Inspire Medical Systems, Inc. (NYSE:INSP) Q3 2024 Earnings Conference Call November 4, 2024 5:00 PM ET
Company Participants
Ezgi Yagci – Vice President-Investor Relations
Tim Herbert – President and Chief Executive Officer
Rick Buchholz – Chief Financial Officer
Conference Call Participants
Robbie Marcus – JPMorgan
Danielle Antalffy – UBS
Travis Steed – Bank of America Securities
Adam Maeder – Piper Sandler
David Rescott – Baird
Michael Sarcone – Jefferies
Richard Newitter – Truist Securities
Larry Biegelsen – Wells Fargo
Shagun Singh – RBC
Kallum Titchmarsh – Morgan Stanley
Jon Block – Stifel
Anthony Petrone – Mizuho Americas
Brett Fishbin – KeyBanc Capital Markets
Chris Pasquale – Nephron Research
Michael Polark – Wolfe Research
Mike Kratky – Leerink Partners
Suraj Kalia – Oppenheimer & Co
Operator
Good afternoon. My name is Dilem, and I’ll be your conference operator today. At this time, I’d like to welcome everyone to the Inspire Medical Systems Third Quarter 2024 Conference Call. All lines have been placed on mute to prevent any background noise. After the speakers’ remarks, there will be a question-and-answer session.
I’ll now hand the call over to your first speaker, Ezgi Yagci, the Vice President of Investor Relations at Inspire. You may begin the conference.
Ezgi Yagci
Thank you, Dilem, and thank you all for participating in today’s call. Joining me are Tim Herbert, Chairman and Chief Executive Officer; and Rick Buchholz, Chief Financial Officer. Earlier today, we released financial results for the three and nine months ended September 30, 2024. A copy of the press release is available on our website.
On this call, management will make forward-looking statements within the meaning of the federal securities laws. All forward-looking statements, including, without limitation, those relating to our operations, financial results and financial conditions, investments in our business, full year 2024 financial and operational outlook and changes in market access
